The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Inge Marie Svane Per thor Straten Morten Orebo Holmström Özcan Met Mads Hald Andersen |
| Publication date | July 5, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |